In the BioHarmony Drug Report Database
Chlorotrianisene
Tace (chlorotrianisene) is a small molecule pharmaceutical. Chlorotrianisene was first approved as Tace on 1982-01-01. It is used to treat hypogonadism, premature menopause, and prostatic neoplasms in the USA.
Trade Name
|
Tace |
|---|---|
Common Name
|
chlorotrianisene |
ChEMBL ID
|
CHEMBL1200761 |
Indication
|
hypogonadism, premature menopause, prostatic neoplasms |
Drug Class
|
Nonsteroidal estrogen |
Image (chem structure or protein)